LONDON (MarketWatch) -- Indian generic drugmaker Ranbaxy Laboratories Ltd. (500359.BY) Monday said it has received tentative approval from the U.S. Food and Drug Administration to sell generic copies ...
MUMBAI, June 27 (Reuters) - India's Ranbaxy Laboratories rose 5.8 percent in early trading after the U.S. Food and Drug Administration said on Thursday it had approved the company's generic version of ...
MUMBAI (Reuters) - Ranbaxy Laboratories rose 5.8 percent in early trading after the U.S. Food and Drug Administration said on Thursday it had approved the company's generic version of Novartis AG's ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results